Outdexing Proprietary Limited (“OPL”), and its antecedents from 2010, developed a novel portfolio management strategy, it is called Outdexing©, to provide investors a better return and risk profile.
All the intellectual property referring to Outdexing is claimed by OPL.
The directors of OPL are:
- Peter Dobrijevic, Bachelor of Engineering (BE), Master of Business Administration (MBA), Diploma in Law (DipLaw); and,
- Ellen Dobrijevic, Bachelor of Science in Engineering (BSE), Doctor of Medicine (MD).
Mr Dobrijevic is an engineer, financier/investor and lawyer who provides consulting services on Outdexing after more than 30 years in financial services. His stock analysis experience was recognised by large institutional investment managers by his #1 ranking in a number of industry surveys. Later he translated those skills to portfolio management where at one point was managing $300m of client money. During the Global Financial Crisis, he outperformed his benchmark by 8.75% on a cumulative basis.
Dr Dobrijevic is an engineer, medical doctor and PhD candidate in nephrology. In 2024 she commenced training as a specialist in internal medicine at a large Sydney teaching hospital. Dr Dobrijevic topped her classes at Princeton University (Chemical and Biological Engineering, 2017) and at the University of Sydney (M.D., 2021). In addition to her duties as a director, she provides high level mathematical insights to OPL.
Most importantly, the Dobrijevic family have significant amounts invested in the Outdexing products so there is an alignment of interests. Every fund offered using Outdexing’s intellectual property has the Dobrijevic family as investors.
The company has applied for an Australian Financial Services Licence (“AFSL”) from the government regulator. Until it is granted an AFSL, OPL will NOT advise on, or deal with, financial products for external clients.